{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:39Z","timestamp":1783606959550,"version":"3.55.0"},"reference-count":44,"publisher":"Bioscientifica","issue":"1","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:p>With increased use of somatostatin analogue (SSA) PET\/CT, the prevalence of incidentaloma \u2013 at present approximately 4.5% \u2013 is anticipated to rise. As malignancy has been reported in 13% of all cases, these incidentaloma are clinically relevant. However, because of publication bias, prevalence is probably underestimated and the malignancy rate overestimated. Therefore, we assessed the prevalence, cause, malignancy rate, and tracer uptake intensity on 68Ga-DOTANOC PET. All 68Ga-DOTANOC PET\/CT protocols in adults, performed between 2017 and 2024 at Antwerp University Hospital, were retrospectively screened for incidentaloma. Patient records were examined to determine the cause of non-physiological increased tracer uptake. A total of 1,951 68Ga-DOTANOC PET\/CTs were performed in 1,102 subjects. A total of 145 incidentaloma (13.2%) were described in 136 subjects (mean age 64 \u00b1 13 years; F\/M 82\/54), most commonly in the thyroid (n = 43), brain (n = 31), prostate (n = 23), and breast (n = 11). The cause of pathological tracer uptake was evaluated by additional imaging in 55% of incidentaloma, whereby benign thyroid nodules, meningioma, benign prostatic hyperplasia, and breast fibroma and carcinoma were the most common findings, respectively. The malignancy rate was low (6%), comprising two breast cancers, one prostate cancer, one renal cell carcinoma, and one lung cancer. This is the largest single-centre study describing the prevalence and cause of 68Ga-DOTANOC incidentaloma to date. While the prevalence is significantly higher (13.2%) than described in previous studies (4.5%), the malignancy rate was significantly lower (6 versus 13%), as was expected due to publication bias, and no thyroid cancer was diagnosed.<\/jats:p>","DOI":"10.1530\/erc-25-0251","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T11:06:30Z","timestamp":1765796790000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["The prevalence and clinical significance of 68Ga-DOTANOC incidentaloma"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9068-2575","authenticated-orcid":true,"given":"L","family":"Naert","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Stroobants","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Vandamme","sequence":"additional","affiliation":[{"name":"3"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"De Block","sequence":"additional","affiliation":[{"name":"1"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"De Herdt","sequence":"additional","affiliation":[{"name":"1"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2026070909450020500_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2214\/AJR.18.19881","article-title":"Neuroendocrine tumor diagnosis and management: (68)Ga-DOTATATE PET\/CT","volume":"211","author":"Sanli","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"2026070909450020500_bib2","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2217\/fon.14.139","article-title":"PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature","volume":"10","author":"Johnbeck","year":"2014","journal-title":"Future Oncol"},{"key":"2026070909450020500_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2967\/jnmt.117.203448","article-title":"Can (68)Ga-DOTA peptides be potential radiotracers for PET imaging of the spleen?","volume":"46","author":"Sarikaya","year":"2018","journal-title":"J Nucl Med Technol"},{"key":"2026070909450020500_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40644-022-00484-0","article-title":"Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET\/CT: a systematic review of the literature","volume":"22","author":"Bentestuen","year":"2022","journal-title":"Cancer Imaging"},{"key":"2026070909450020500_bib5","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2214\/AJR.14.12588","article-title":"Neuroendocrine tumor imaging with 68Ga-DOTA-NOC: physiologic and benign variants","volume":"203","author":"Kagna","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"2026070909450020500_bib6","first-page":"61","article-title":"Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions","volume":"54","author":"Prasad","year":"2010","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2026070909450020500_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/medicina58070916","article-title":"Prevalence of brain incidental lesions detected by (68)Ga-DOTA peptides PET\/CT","volume":"58","author":"Albano","year":"2022","journal-title":"Medicina"},{"key":"2026070909450020500_bib8","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA","volume":"44","author":"Bozkurt","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070909450020500_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5603\/EP.2015.0030","article-title":"How often do we see incidental 68Ga-DOTATATE thyroid uptake in PET\/CT in patients with neuroendocrine tumours?","volume":"66","author":"Kunikowska","year":"2015","journal-title":"Endokrynol Pol"},{"key":"2026070909450020500_bib10","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0419","article-title":"Abnormal uptake related to the thyroid gland on somatostatin receptor-targeted PET imaging: reported prevalence and rate of thyroid malignancy and parathyroid adenomas","volume":"13","author":"Sjostedt","year":"2024","journal-title":"Endocr Connect"},{"key":"2026070909450020500_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/thy.2016.0174","article-title":"The rate and clinical significance of incidental thyroid uptake as detected by Gallium-68 DOTATATE positron emission tomography\/computed tomography","volume":"26","author":"Nockel","year":"2016","journal-title":"Thyroid"},{"key":"2026070909450020500_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/RLU.0000000000001950","article-title":"Incidental detection of medullary thyroid carcinoma by 68Ga-DOTATATE PET\/CT in a patient with neuroendocrine tumor liver metastases","volume":"43","author":"Mahajan","year":"2018","journal-title":"Clin Nucl Med"},{"key":"2026070909450020500_bib13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/MNM.0b013e328364eaab","article-title":"Evaluation and comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-NOC PET\/CT imaging in well-differentiated thyroid cancer","volume":"34","author":"Ocak","year":"2013","journal-title":"Nucl Med Commun"},{"key":"2026070909450020500_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/thy.2009.0203","article-title":"Somatostatin receptor 2 expression determined by immunohistochemistry in cold thyroid nodules exceeds that of hot thyroid nodules, papillary thyroid carcinoma, and Graves\u2019 disease","volume":"20","author":"Sancak","year":"2010","journal-title":"Thyroid"},{"key":"2026070909450020500_bib15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/iep.12024","article-title":"Somatostatin receptor expression in thyroid disease","volume":"94","author":"Atkinson","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"2026070909450020500_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/wjnm.wjnm_39_18","article-title":"Prevalence of hitherto unknown brain meningioma detected on (68)Ga-DOTATATE positron-emission tomography\/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of (177)Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors","volume":"18","author":"Parghane","year":"2019","journal-title":"World J Nucl Med"},{"key":"2026070909450020500_bib17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/MNM.0000000000000571","article-title":"The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients","volume":"37","author":"Cleary","year":"2016","journal-title":"Nucl Med Commun"},{"key":"2026070909450020500_bib18","volume-title":"Primary brain and other central nervous system tumours in adults in Belgium 2004\u20132020","author":"Tambuyzer","year":"2023"},{"key":"2026070909450020500_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neuro Oncol"},{"key":"2026070909450020500_bib20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","article-title":"Detection of cranial meningiomas: comparison of (6)(8)Ga-DOTATOC PET\/CT and contrast-enhanced MRI","volume":"39","author":"Afshar-Oromieh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070909450020500_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2967\/jnumed.114.149120","article-title":"Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue","volume":"56","author":"Rachinger","year":"2015","journal-title":"J Nucl Med"},{"key":"2026070909450020500_bib22","doi-asserted-by":"crossref","first-page":"i44","DOI":"10.1093\/neuonc\/noy143","article-title":"Imaging and diagnostic advances for intracranial meningiomas","volume":"21","author":"Huang","year":"2019","journal-title":"Neuro Oncol"},{"key":"2026070909450020500_bib23","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/diagnostics12071666","article-title":"Somatostatin receptor targeted PET-imaging for diagnosis, radiotherapy planning and theranostics of meningiomas: a systematic review of the literature","volume":"12","author":"Filippi","year":"2022","journal-title":"Diagnostics"},{"key":"2026070909450020500_bib24","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2214\/AJR.13.10987","article-title":"Somatostatin receptor-based PET\/CT of intracranial tumors: a potential area of application for 68 Ga-DOTA peptides?","volume":"201","author":"Sharma","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"2026070909450020500_bib25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2967\/jnumed.123.266956","article-title":"Peptide receptor radionuclide therapy in advanced refractory meningiomas: efficacy and toxicity in a long follow-up","volume":"65","author":"Severi","year":"2024","journal-title":"J Nucl Med"},{"key":"2026070909450020500_bib26","first-page":"94","article-title":"Clinical significance of atypical (68)Ga-DOTATOC prostatic uptake on PET\/CT: a ten-year review","volume":"26","author":"Gossili","year":"2023","journal-title":"Hell J Nucl Med"},{"key":"2026070909450020500_bib27","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00259-011-1760-x","article-title":"68Ga-DOTATOC PET\/CT and somatostatin receptor (Sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax","volume":"38","author":"Boy","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070909450020500_bib28","first-page":"108","article-title":"Gallium-68 DOTATOC PET\/CT in vivo characterization of somatostatin receptor expression in the prostate","volume":"29","author":"Todorovic-Tirnanic","year":"2014","journal-title":"Cancer Biother Radiopharm"},{"key":"2026070909450020500_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/039463201002300213","article-title":"Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation","volume":"23","author":"Morichetti","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2026070909450020500_bib30","first-page":"273","article-title":"Neuroendocrine differentiation of prostate cancer: a review","volume":"2","author":"Parimi","year":"2014","journal-title":"Am J Clin Exp Urol"},{"key":"2026070909450020500_bib31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"Hofman","year":"2015","journal-title":"Radiographics"},{"key":"2026070909450020500_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12149-020-01570-8","article-title":"Somatostatin receptor-positive breast lesions on 68Ga-DOTATATE PET\/CT","volume":"35","author":"Has Simsek","year":"2021","journal-title":"Ann Nucl Med"},{"key":"2026070909450020500_bib32","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1097\/RLU.0000000000001620","article-title":"68Ga-DOTATATE PET\/CT in nonneuroendocrine tumors: a pictorial essay","volume":"42","author":"Yamaga","year":"2017","journal-title":"Clin Nucl Med"},{"key":"2026070909450020500_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011878","article-title":"Incidental finding of a breast carcinoma on Ga-68-DOTA-1-Nal3-octreotide positron emission tomography\/computed tomography performed for the evaluation of a pancreatic neuroendocrine tumor: a case report","volume":"97","author":"Sampaio Vieira","year":"2018","journal-title":"Medicine"},{"key":"2026070909450020500_bib34","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.radcr.2020.05.054","article-title":"Incidental primary breast cancer detected on surveillance (68)Ga-DOTATATE PET\/CT in a patient with metastatic neuroendocrine carcinoma","volume":"15","author":"Ambinder","year":"2020","journal-title":"Radiol Case Rep"},{"key":"2026070909450020500_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/RLU.0000000000003421","article-title":"68Ga-DOTATATE uptake in primary breast cancer","volume":"46","author":"Guirguis","year":"2021","journal-title":"Clin Nucl Med"},{"key":"2026070909450020500_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.5603\/ep.103949","article-title":"Incidentally detected breast cancer in [68Ga]Ga-DOTA-TATE PET\/CT in a patient with diagnosed pancreatic neuroendocrine tumour","volume":"75","author":"Zemczak","year":"2024","journal-title":"Endokrynol Pol"},{"key":"2026070909450020500_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamaoncol.2023.4837","article-title":"Global stage distribution of breast cancer at diagnosis: a systematic review and meta-analysis","volume":"10","author":"Benitez Fuentes","year":"2024","journal-title":"JAMA Oncol"},{"key":"2026070909450020500_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3413\/nukmed-0185","article-title":"Incidental detection of breast cancer by 68Ga-DOTATOC-PET\/CT in women suffering from neuroendocrine tumours","volume":"47","author":"Elgeti","year":"2008","journal-title":"Nuklearmedizin"},{"key":"2026070909450020500_bib39","first-page":"2974","article-title":"Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma","volume":"80","author":"Vikic-Topic","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909450020500_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/RLU.0000000000000351","article-title":"Molecular imaging of late somatostatin receptor-positive metastases of renal cell carcinoma in the pancreas by 68Ga DOTATOC PET\/CT: a rare differential diagnosis to multiple primary pancreatic neuroendocrine tumors","volume":"39","author":"Peter","year":"2014","journal-title":"Clin Nucl Med"},{"key":"2026070909450020500_bib41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/RLU.0000000000002718","article-title":"68Ga-DOTATATE uptake in pancreatic metastasis of renal cell carcinoma mimicking pancreatic neuroendocrine tumor","volume":"44","author":"Soydal","year":"2019","journal-title":"Clin Nucl Med"},{"key":"2026070909450020500_bib42","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.21037\/qims-24-1828","article-title":"False positive of (68)Ga-DOTATATE uptake in multiple duodenum and pancreatic metastasis of renal clear cell carcinoma: a case description","volume":"15","author":"Wang","year":"2025","journal-title":"Quant Imaging Med Surg"},{"key":"2026070909450020500_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.6058\/jlc.2011.10.2.69","article-title":"Somatostatin receptors in lung cancer: from function to molecular imaging and therapeutics","volume":"10","author":"Callison","year":"2011","journal-title":"J Lung Cancer"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/1\/ERC-25-0251.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/1\/ERC-25-0251.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0251\/505985\/erc-25-0251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0251\/505985\/erc-25-0251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:45:11Z","timestamp":1783604711000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/1\/e250251\/75543\/The-prevalence-and-clinical-significance-of-68Ga"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0251","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"e250251"}}